Semler Scientific, Inc. (SMLR)
- Previous Close
35.37 - Open
35.41 - Bid 33.72 x 100
- Ask 34.15 x 200
- Day's Range
33.34 - 35.54 - 52 Week Range
20.88 - 81.56 - Volume
508,227 - Avg. Volume
369,000 - Market Cap (intraday)
348.536M - Beta (5Y Monthly) 1.30
- PE Ratio (TTM)
6.89 - EPS (TTM)
4.93 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
www.semlerscientific.comRecent News: SMLR
View MorePerformance Overview: SMLR
Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SMLR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SMLR
View MoreValuation Measures
Market Cap
334.74M
Enterprise Value
319.89M
Trailing P/E
6.62
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.82
Price/Book (mrq)
1.45
Enterprise Value/Revenue
5.68
Enterprise Value/EBITDA
14.87
Financial Highlights
Profitability and Income Statement
Profit Margin
72.65%
Return on Assets (ttm)
8.23%
Return on Equity (ttm)
27.04%
Revenue (ttm)
56.29M
Net Income Avi to Common (ttm)
40.9M
Diluted EPS (ttm)
4.93
Balance Sheet and Cash Flow
Total Cash (mrq)
14.92M
Total Debt/Equity (mrq)
0.03%
Levered Free Cash Flow (ttm)
15.49M